Stockhead on MSN
Health Check: Imricor shares soar on the heart device play’s second FDA clearance this month
Two weeks after giving the nod to Imricor's novel ablation catheter, the FDA has cleared the company's overriding 'dashboard' ...
The Farapoint device adds another tool to the company’s pulsed field ablation portfolio that could help increase or sustain its electrophysiology market share, one analyst said.
Medtronic won CE mark for the Affera Sphere-360 catheter and completed the first cases of the device in the Horizon 360 IDE ...
Affera momentum continues as Medtronic announces CE Mark in Europe & US IDE first cases for Sphere-360 PFA catheter to treat paroxysmal atrial fibrillation: Galway, Ireland Tuesda ...
ASX healthcare rises for week ending January 23, 2026 as Morgans' Scott Power says focus shifts to quarterly reporting season ...
Medtronic plc , a global leader in healthcare technology, today announced two major milestones for the Afferatm Sphere-360tm catheter, a first-of-its-kind, all-in-one mapping and single-shot pulsed ...
"A clean, modern medical examination room featuring a professional treatment table with white medical paper, a sleek white leather sofa, and a matching chair. A digital wall monitor displays a ...
Stockhead on MSN
Scott Power: ASX healthcare stocks lift as sentiment improves
Morgans' Scott Power is positive of renewed momentum in the healthcare sector, which has risen 0.9% in the week ending ...
Boston Scientific expects incredibly high growth for its pulsed field ablation (PFA) devices, driven by increased usage of its existing catheters.
Millions of Americans experience an irregular heartbeat, which can be unsettling and scary. When irregular heartbeats happen — and they happen a lot — electrophysiologists have sophisticated solutions ...
The system enters a field that sees PFA catheters largely displacing thermal modalities for catheter ablation of AF.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results